 Peripheral eosinophilia-myalgia syndrome Disease Control existence epidemic illness myalgia eosinophilia individuals preparations L-tryptophan patients eosinophilia-myalgia syndrome subacute progressive neuropathies neuropathies motor maximal extremities patients wheelchair ventilator-dependent bedridden Sensory loss small fiber modalities Electrophysiological studies multifocal marked conduction conduction block segmental demyelination axonal degeneration Examination sural nerve biopsy specimens axonal degeneration patients perivascular infiltrates Levels quinolinic acid neurotoxic metabolite L-tryptophan cerebrospinal fluid patients cause neuropathy unknown immune mechanisms toxicity eosinophils L-tryptophan metabolic products contaminants L-tryptophan preparations